NIH-funded research R21 grant

Endothelial genes linked to Alzheimer's progression in male and female brains

Official title: Identification of endothelial gene targets over Alzheimer s disease progression

Funded at Albany Medical College · NIH-11453764 · Data updated 2026-11-12

Aims to find blood vessel gene targets that change as Alzheimer's progresses, in both men and women, using mouse models to mirror human disease.

More s Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$451,000
NIH project number1R21AG099223-01A1
Project IDNIH-11453764 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals interested in participating in future human studies or who have a risk of Alzheimer’s disease and related dementias.

Less likely to help

People without any link to Alzheimer’s disease or vascular contributions to cognitive impairment may not directly benefit.

What this research studies

This project will study brain blood vessel cells in Alzheimer’s disease over early, middle, and late stages in both sexes. Using two mouse models, researchers will profile the endothelial translatome to see which genes change with disease and vascular pathology. They will connect these gene changes to pathology and cognitive function, and look for sex-specific targets that could be modifiable. The study combines gene data with real-time functional readouts to identify potential new treatment angles. The work is designed to pinpoint targets that are relevant to human disease and could guide future therapies.

Why it matters

Potential benefit: If successful, the research could reveal sex-specific vascular targets for delaying or altering Alzheimer’s progression and inform future therapeutic strategies.

How similar studies have gone: Previous human studies show vascular gene changes in AD, and this project builds on that by adding sex differences and time-course data in animal models; translational potential is promising but still early.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Zuloaga, Kristen Leanne — Albany Medical College
  • Study coordinator: Zuloaga, Kristen Leanne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.